Sweden needs to create a better environment for life science businesses to prevent companies from moving their operations and investments abroad, a report has warned.
The report, Global Trends with Local Effects – The Swedish Life Science Industry 1998-2012, was published this week by Vinnova, the country’s innovation funding agency. Vinnova found that the number of employees in the life science industry has decreased by 4,000 during the period observed, and that 2,200 employees have left since 2009.
Several large companies, such as Astra Zeneca, a multinational pharmaceutical company, have shut down their research and production units in Sweden. Even though some sections of the life sciences industry are growing, this does not compensate for the shut-downs, Vinnova said.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.